Colony Group’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,144
| Closed | -$44K | – | 771 |
|
|
2023
Q1 | $44K | Hold |
5,144
| – | – | ﹤0.01% | 775 |
|
|
2022
Q4 | $68K | Hold |
5,144
| – | – | ﹤0.01% | 817 |
|
|
2022
Q3 | $88K | Hold |
5,144
| – | – | ﹤0.01% | 752 |
|
|
2022
Q2 | $57K | Hold |
5,144
| – | – | ﹤0.01% | 805 |
|
|
2022
Q1 | $114K | Hold |
5,144
| – | – | ﹤0.01% | 824 |
|
|
2021
Q4 | $177K | Hold |
5,144
| – | – | ﹤0.01% | 780 |
|
|
2021
Q3 | $316K | Hold |
5,144
| – | – | 0.01% | 672 |
|
|
2021
Q2 | $401K | Hold |
5,144
| – | – | 0.01% | 580 |
|
|
2021
Q1 | $287K | Hold |
5,144
| – | – | 0.01% | 651 |
|
|
2020
Q4 | $315K | Hold |
5,144
| – | – | 0.01% | 601 |
|
|
2020
Q3 | $626K | Hold |
5,144
| – | – | 0.02% | 435 |
|
|
2020
Q2 | $608K | Hold |
5,144
| – | – | 0.02% | 423 |
|
|
2020
Q1 | $273K | Hold |
5,144
| – | – | 0.01% | 568 |
|
|
2019
Q4 | $280K | Buy |
+5,144
| New | +$280K | 0.01% | 651 |
|